Sign up 3 colleagues for the price of 2 with the coupon code RCDVB!

Agenda | Speakers | Abstract Submission | Venue
Dear Colleague,

GTC is proud to present Diabetes Summit 2014 to be held on April 23 - April 25 in Cambridge, MA. The 2014 Diabetes Summit will continue to feature two concurrent conferences:
1) 4th Diabetes Partnering and Deal-Making Conference - highlights pre-clinical and early clinical research, emerging therapeutic targets, and update guests on clinical developments.
2) 7th Diabetes Drug Discovery and Development Conference - designed to discuss opportunities for partnerships, funding, licensing, and merger and acquisitions.

The Diabetes Summit has evolved to be the go-to conference to learn about the latest research, partnership opportunities and network with academia, venture capital, government, small/medium size biotech, big pharma and healthcare organizations. There is nothing quite like the Diabetes Summit - the combination of research and partnering makes attending worthwhile!

We invite you to join delegates from across the world at the 2014 Diabetes Summit. The program will provide you with opportunities to further your understanding of the diabetes field through presentations and panel discussions within the distinctive conferences.

To view the 2014 detailed agenda, click here.
To view the 2014 speaker list, click here.

April 23, 2014
General Session
Joint sessions with Diabetes Summit and 2014 Stem Cell Summit
I. Cell Therapy and Diabetes - Stem Cell Research in the Diabetes Space

Conference I:
4th Diabetes Partnering and Deal-Making

Conference II:
7th Diabetes Drug Discovery and Development
April 24-25, 2014
Joint Session
• Sethu Reddy, Cleveland Clinic
• Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism, Boehringer Ingelheim

Steven E. Nissen, Chairman of Cardiovascular Medicine, Cleveland Clinic Foundation

Panel Discussion: Type 1 Diabetes: "The New Honeymoon that Last Decades"
- Clinical trial opportunities and the new diverse type 1 diabetic population - can we more accurately predict complications?
Denise Faustman, Harvard Medical School
Corinth Auld, Mercodia
Richard Oram, Exeter

Diabetes Partnering and Deal-Making
Diabetes Drug Discovery and Development
I. Innovative Partnering & Licensing Strategies
II. Partnering Opportunities in Diabetes Drug Development
III. Current Trends & Recent Deals
Panel Discussions:
I. Wining Strategies in Partnering & Deal-Making
II. Partnering with Non-Profits
III. Finding the Middle Ground in Big Pharma and Biotech Partnerships
IV. Partnering with Academia
V. Investment Opportunities in the Diabetes Space

For a detailed agenda & participants click here

I. New Therapeutic Targets for Diabetes
II. Combination Therapy
III. Clinical Drug Development in Diabetes
IV. Advances in Obesity Drug Development

For a detailed agenda & participants click here

Sign up for the summit pass to have access to both conferences of the summit. Or bring a team of 3 for the price of 2 by registering with the coupon code rcdvb!

We look forward to seeing you at the conference!

Best regards,

2014 Conference Advisory Committee

Attend ALL GTC Conferences for One Year for only $3,995 ($1,990 for Acad/Govt).
Click here to sign up!

John Brooks
President & CEO
Joslin Diabetes Center
Ralph A. DeFronzo
Professor of Medicine and Chief of the Diabetes Division University of Texas Health Science Center; Audie L. Murphy Memorial VA Hospital
Steven E. Nissen
Chairman of Cardiovascular Medicine
Cleveland Clinic Foundation
Prabhakar Viswanathan
Senior Medical Director, Diabetes & Metabolism
Takeda Pharmaceuticals
Hans-Juergen Woerle

Vice President Medicine Therapeutic Area Metabolism
Boehringer Ingelheim
"This conference was a very good opportunity to strengthen the connection between big pharma, biotech and academics, through a good mix between panel discussion, case studies, companies presentation and networking opportunity." - CEO, Poxel
"Excellent conference to engage with industry and academic collaborators and to learn about advances in technology in a setting that is very conducive to discussion and networking." - CEO, Joslin Diabetes Center
"The GTC Diabetes Summit converged stakeholders in discovery, translational development, commercialization and care delivery in a diabetes-focused conference that stimulated discussion, ideas, and networking so critical for advancing innovation to address the current global challenges. It was a high-value, engaging conference.” CEO, Exsulin